Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
See how to make money instead of spending it on Black Friday with this offer (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:REGN

Regeneron Pharmaceuticals - REGN SEC Filings & 10K Form

$736.23
+0.87 (+0.12%)
(As of 11/25/2022 08:58 PM ET)
Add
Compare
Today's Range
$728.61
$737.24
50-Day Range
$684.63
$759.91
52-Week Range
$538.01
$769.63
Volume
229,200 shs
Average Volume
706,396 shs
Market Capitalization
$80.18 billion
P/E Ratio
15.52
Dividend Yield
N/A
Price Target
$766.81

Recent Regeneron Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/25/2022
12:07 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
3:05 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2022
6:25 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2022
6:19 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2022
3:06 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2022
8:03 AM
FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G/A
10/07/2022
3:03 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2022
3:11 PM
Regeneron Pharmaceuticals (Issuer)
Thompson Craig B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2022
3:11 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2022
3:10 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2022
3:10 PM
Regeneron Pharmaceuticals (Issuer)
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2022
3:04 PM
Regeneron Pharmaceuticals (Issuer)
Thompson Craig B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/03/2022
3:05 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2022
6:17 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2022
3:31 PM
Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2022
3:30 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2022
3:07 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/08/2022
3:06 PM
COLES N ANTHONY (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2022
3:07 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2022
3:04 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
6:21 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2022
6:08 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2022
3:28 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2022
3:11 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2022
6:36 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2022
7:38 AM
Checkmate Pharmaceuticals, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
Form SC TO-T/A
05/20/2022
3:37 PM
Checkmate Pharmaceuticals, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
Form SC TO-T/A
05/11/2022
4:01 PM
Checkmate Pharmaceuticals, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
Form SC TO-T/A
05/04/2022
6:17 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2022
6:08 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2022
6:48 AM
Checkmate Pharmaceuticals, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
Form SC TO-T
04/21/2022
3:21 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
04/21/2022
3:15 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
04/21/2022
3:09 PM
Regeneron Pharmaceuticals (Filer)
Form DEF 14A
04/19/2022
3:50 PM
Checkmate Pharmaceuticals, Inc. (Subject)
Regeneron Pharmaceuticals (Filed by)
Form SC TO-C
09/15/2021
3:03 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2021
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2021
3:02 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2021
3:05 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2021
3:01 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2021
3:06 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4/A
08/17/2021
3:17 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2021
3:16 PM
Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2021
4:19 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:55 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:54 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:00 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2021
4:00 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2021
6:11 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
5:59 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/04/2021
3:03 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2021
3:01 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2021
3:03 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:03 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/08/2021
3:02 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2021
6:21 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2021
6:12 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2021
6:12 AM
Regeneron Pharmaceuticals (Filer)
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2021
3:21 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
04/23/2021
3:16 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
02/18/2021
3:01 PM
Decibel Therapeutics, Inc. (Issuer)
Regeneron Pharmaceuticals (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2021
4:01 PM
Decibel Therapeutics, Inc. (Issuer)
Regeneron Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/10/2021
10:47 AM
Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/08/2021
8:13 AM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/05/2021
6:34 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2021
7:23 AM
BlackRock Inc. (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G/A
01/15/2021
3:01 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2021
5:03 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
3:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:07 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
3:04 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:03 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
4:30 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:07 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:06 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:06 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:05 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:04 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:03 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2020
3:09 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:02 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
4:57 PM
COLES N ANTHONY (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2020
6:48 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
6:32 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/03/2020
4:22 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/23/2020
3:02 PM
MURPHY ANDREW J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:09 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/06/2020
3:07 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2020
3:13 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:01 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/23/2020
3:00 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:18 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:37 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:36 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/31/2020
3:35 PM
POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:23 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2020
3:21 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2020
5:14 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:REGN) was last updated on 11/28/2022 by MarketBeat.com Staff